MobiHealthNews (6/26, Comstock) reports the Food and Drug Administration has cleared the DentiTrac device, “an oral device for treating sleep apnea.” The device itself “is from Australian company SomnoMed and the tracker is from Braebon Medical Corporation” of Ontario, Canada. The piece notes that the device “is the first partner device to receive FDA clearance.”
No comments:
Post a Comment